Why is the market design for innovative pharmaceuticals not well understood?
Saved in:
| Title: | Why is the market design for innovative pharmaceuticals not well understood? |
|---|---|
| Authors: | Olivença F; Lane Clark & Peacock LLP, London, W1U 1DQ, UK., Diaz J; Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK., Ramagopalan SV; Lane Clark & Peacock LLP, London, W1U 1DQ, UK.; Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK., Garrison LP Jr; The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA. |
| Source: | Journal of comparative effectiveness research [J Comp Eff Res] 2024 Oct; Vol. 13 (10), pp. e240105. Date of Electronic Publication: 2024 Sep 10. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: Becaris Publishing Country of Publication: England NLM ID: 101577308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6313 (Electronic) Linking ISSN: 20426305 NLM ISO Abbreviation: J Comp Eff Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39254992 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Why is the market design for innovative pharmaceuticals not well understood? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Olivença+F%22">Olivença F</searchLink>; Lane Clark & Peacock LLP, London, W1U 1DQ, UK.<br /><searchLink fieldCode="AU" term="%22Diaz+J%22">Diaz J</searchLink>; Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK.<br /><searchLink fieldCode="AU" term="%22Ramagopalan+SV%22">Ramagopalan SV</searchLink>; Lane Clark & Peacock LLP, London, W1U 1DQ, UK.; Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK.<br /><searchLink fieldCode="AU" term="%22Garrison+LP+Jr%22">Garrison LP Jr</searchLink>; The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101577308%22">Journal of comparative effectiveness research</searchLink> [J Comp Eff Res] 2024 Oct; Vol. 13 (10), pp. e240105. <i>Date of Electronic Publication: </i>2024 Sep 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Becaris+Publishing%22">Becaris Publishing </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101577308 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2042-6313 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220426305%22">20426305 </searchLink><i>NLM ISO Abbreviation: </i>J Comp Eff Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39254992 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.57264/cer-2024-0105 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e240105 Titles: – TitleFull: Why is the market design for innovative pharmaceuticals not well understood? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Olivença F – PersonEntity: Name: NameFull: Diaz J – PersonEntity: Name: NameFull: Ramagopalan SV – PersonEntity: Name: NameFull: Garrison LP Jr IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2042-6313 Numbering: – Type: volume Value: 13 – Type: issue Value: 10 Titles: – TitleFull: Journal of comparative effectiveness research Type: main |
| ResultId | 1 |